Alan Tyndall active positions
| Companies | Position | Start | End |
|---|---|---|---|
| University of Basel | Corporate Officer/Principal | 1990-12-31 | - |
| World Scleroderma Foundation | Corporate Secretary | - | - |
| Iterata AG | Director/Board Member | - | - |
| Founder | - | - |
Career history of Alan Tyndall
Former positions of Alan Tyndall
| Companies | Position | Start | End |
|---|---|---|---|
| MAGENTA THERAPEUTICS | Founder | 2015-06-16 | - |
Training of Alan Tyndall
| The University of Sydney | Undergraduate Degree |
Statistics
International
| Switzerland | 4 |
| Australia | 2 |
| United States | 2 |
Operational
| Founder | 2 |
| Corporate Officer/Principal | 1 |
| Corporate Secretary | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
| World Scleroderma Foundation | |
| Iterata AG |
- Stock Market
- Insiders
- Alan Tyndall
- Experience
